Uncommon phenotypes of acute myelogenous leukemia: Basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: A review

被引:16
|
作者
Lichtman, MA [1 ]
Segel, GB
机构
[1] Univ Rochester, Med Ctr, Dept Med Hematol Oncol, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Pediat Hematol Oncol Genet, Rochester, NY 14642 USA
[4] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA
关键词
myelogenous leukemia; basophilic leukemia; mast cell leukemia; eosinophilic leukemia; dendritic cell leukemia; clonal myeloid diseases; leukemia classification;
D O I
10.1016/j.bcmd.2005.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The potential of the transformed (leukemic) multipotential hematopoietic cell to differentiate and mature along any myeloid lineage forms the basis for the phenotypic classification of acute and chronic myelogenous leukemia. Although most cases of leukemia can be classified phenotypically by the dominant lineage expressed, the genotype within each phenotype is heterogeneous. Thus, covert genetic factors, cryptic mutations, and/or polymorphisms may interact with the seminal transforming genetic mutations to determine phenotype. The phenotype usually is expressed sufficiently to determine the lineage that is dominant in the leukemic clone by light microscopic examination, by cytochemistry of blood and marrow cells, and by immunophenotyping. The basis for the frequency of the AML phenotypes is unclear, although there is a rough concordance with the frequency of marrow precursor cells of different lineages. The least common AML phenotypes are a reflection of the least common blood or marrow cell lineages: acute basophilic, acute mast cell, acute eosinophilic, and acute myeloid dendritic cell leukemia. We discuss the features of these uncommon phenotypes and review the criteria used for their diagnosis. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:370 / 383
页数:14
相关论文
共 50 条
  • [1] Dendritic cell vaccination in acute myeloid leukemia
    Anguille, Sebastien
    Willemen, Yannick
    Lion, Eva
    Smits, Evelien L.
    Berneman, Zwi N.
    [J]. CYTOTHERAPY, 2012, 14 (06) : 647 - 656
  • [2] Complex Karyotype Acute Basophilic Leukemia with Reactive Mast Cell Hyperplasia
    Wu, Yiping
    Zhang, Xiaofang
    Guo, Hongxia
    Guo, Jia
    Li, Ruimin
    [J]. CLINICAL LABORATORY, 2023, 69 (09) : 1995 - 1998
  • [3] Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review
    Khanmiri, Jamal Motallebzadeh
    Alizadeh, Mohsen
    Esmaeili, Sina
    Gholami, Zeinab
    Safarzadeh, Ali
    Khani-Eshratabadi, Mohammad
    Baghbanzadeh, Amir
    Alizadeh, Nazila
    Baradaran, Behzad
    [J]. CYTOTHERAPY, 2024, 26 (05) : 427 - 435
  • [4] A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia
    Hsu, Jennifer
    Bryant, Christian
    Fromm, Phillip
    Papadimitrious, Michael
    Orellana, Daniel
    Suen, Hayley
    Yang, Shihong
    Weatherburn, Claire
    Gasiorowski, Robin
    Iland, Harry J.
    Brown, Ross D.
    Joshua, Douglas E.
    Ho, Phoebe Joy
    Gibson, John
    Clark, Georgina
    Hart, Derek N. J.
    [J]. BLOOD, 2016, 128 (22)
  • [5] Plasmacytoid Dendritic Cell Infiltration in Acute Myeloid Leukemia
    Zhu, Lidan
    Wang, Ping
    Zhang, Wei
    Li, Qiong
    Xiong, Jingkang
    Li, Jiali
    Deng, Xiaojuan
    Liu, Yao
    Yang, Chao
    Kong, Peiyan
    Peng, Xiangui
    Zhong, Jiang F.
    Rao, Jun
    Zhang, Xi
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11411 - 11419
  • [6] Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia
    Siitonen, T
    Lundstrom, M
    Zheng, A
    Savolainen, ER
    Koistinen, P
    [J]. ANNALS OF HEMATOLOGY, 1996, 73 (02) : 71 - 78
  • [7] ACUTE MYELOID DENDRITIC CELL LEUKEMIA-CASE REPORT
    Kopeczi, Judit Beata
    Benedek, Istvan
    Lazar, Erzsebet Benedek
    Kakucs, Eniko
    Tunyogi, Aliz Beata
    Istrati, Monica
    Kurtus, Aranka
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 395 - 396
  • [8] Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
    Houtenbos, Ilse
    Westers, Theresia M.
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    [J]. IMMUNOBIOLOGY, 2006, 211 (6-8) : 677 - 685
  • [9] Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
    Van Acker, Heleen H.
    Versteven, Maarten
    Lichtenegger, Felix S.
    Roex, Gils
    Campillo-Davo, Diana
    Lion, Eva
    Subklewe, Marion
    Van Tendeloo, Viggo F.
    Berneman, Zwi N.
    Anguille, Sebastien
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [10] MAST-CELL SARCOMATOSIS OF THE BONE-MARROW WITH ACUTE MYELOGENOUS LEUKEMIA
    JAGER, K
    THIEL, E
    SCHLAG, R
    SOMMERFELD, W
    BARTL, R
    [J]. BLUT, 1984, 49 (03): : 275 - 275